COPD: statins reduce overall and pulmonary-related mortality

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Statin use was associated with reduced all-cause and pulmonary-related mortality in patients with COPD.

Why this matters

Key results

  • 7775 (19.6%) patients with COPD received ≥1 statin within a year of first COPD medication. In multivariate analysis, statin use was associated with improved all-cause (adjusted HR [aHR], 0.791; P=.0016) and pulmo...